Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombotic Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01621204
What this trial is testing

A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients

Who this might be right for
Immune Thrombocytopenic Purpura
McMaster University 74
Testing effectiveness (Phase 2)Study completedNCT05289947
What this trial is testing

MLC1501 Study Assessing Efficacy in Post STrOke Subjects With mOtor Deficits

Who this might be right for
StrokeStroke, IschemicStrokes Thrombotic+4 more
Moleac Pte Ltd. 303
Large-scale testing (Phase 3)Study completedNCT03252925
What this trial is testing

A Safety and Efficacy Study of NAC in Patients With TA-TMA

Who this might be right for
Thrombotic MicroangiopathiesHematologic Diseases
The First Affiliated Hospital of Soochow University 170
Testing effectiveness (Phase 2)WithdrawnNCT03303313
What this trial is testing

An Investigational Drug, Cemdisiran (ALN-CC5), in Patients With Atypical Hemolytic Uremic Syndrome

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Alnylam Pharmaceuticals
Testing effectiveness (Phase 2)WithdrawnNCT06182410
What this trial is testing

Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma

Who this might be right for
Transplant-Associated Thrombotic MicroangiopathyNeuroblastomaHigh-risk Neuroblastoma+1 more
University of California, San Francisco
Not applicableStudy completedNCT06565364
What this trial is testing

Immunogenicity and Thrombotic Potential of Circulating Protamine-heparin Complexes in Cardiac Surgery Patients

Who this might be right for
ThrombocytopeniaAntibodies Drug Specific
Medical University of Vienna 160
Testing effectiveness (Phase 2)UnknownNCT00107913
What this trial is testing

Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura

Who this might be right for
Autoimmune Thrombocytopenic Purpura
Hematology and Oncology Specialists 10
Not applicableStudy completedNCT05613296
What this trial is testing

Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP

Who this might be right for
ITP - Immune ThrombocytopeniaChronic ITPRefractory ITP
Gruppo Italiano Malattie EMatologiche dell'Adulto 95
Not applicableLooking for participantsNCT07353424
What this trial is testing

Randomized Clinical Trial Compared With Standard Clinical Practice to Evaluate the Efficacy of a Polyphenol-rich Salicornia Extract in the Progression of Cognitive Decline in a Cohort of Patients With Lacunar Infarcts (SALACUNAR)

Who this might be right for
Lacunar Stroke
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 300
Large-scale testing (Phase 3)Study completedNCT00151840
What this trial is testing

Efficacy and Safety of IVIG-L in ITP Patients

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Prothya Biosolutions 20
Not applicableStudy completedNCT07150286
What this trial is testing

Helicobacter Pylori Eradication Therapy for Immune Thrombocytopenia (ITP) Patients in Iraq

Who this might be right for
Immune Thrombocytopenic PurpuraHELICOBACTER PYLORI INFECTIONS
Al-Mustansiriyah University 100
Large-scale testing (Phase 3)Ended earlyNCT04839224
What this trial is testing

Comparing Between CO2 and Phenylephrine Treatment in Patients With Progressive Lacunar Infarction (CARBOGEN Study)

Who this might be right for
Acute Ischemic Stroke
Yonsei University 3
Not applicableLooking for participantsNCT05694325
What this trial is testing

Biologic Characterization of Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Gruppo Italiano Malattie EMatologiche dell'Adulto 200
Testing effectiveness (Phase 2)Study completedNCT00838513
What this trial is testing

Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS)

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Alexion Pharmaceuticals, Inc. 15
Not applicableNot Yet RecruitingNCT06929182
What this trial is testing

OBServaToIre interNational Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux Directs

Who this might be right for
Antiphospholipid Syndrome (APS)Direct Oral Anticoagulants (DOACs)Thrombotic and Bleeding Events+1 more
Central Hospital, Nancy, France 500
Not applicableLooking for participantsNCT07178925
What this trial is testing

Follow-up Cohort of Patients With Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid Syndrome (APS)
University Hospital, Rouen 200
Testing effectiveness (Phase 2)Ended earlyNCT00726544
What this trial is testing

Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy

Who this might be right for
Thrombotic MicroangiopathyThrombotic Thrombocytopenic Purpura
Archemix Corp. 100
Testing effectiveness (Phase 2)Looking for participantsNCT07421167
What this trial is testing

Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)Primary Evans Syndrome (ES)
Novartis Pharmaceuticals 164
Not applicableStudy completedNCT01779401
What this trial is testing

Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients

Who this might be right for
Coronary Heart Disease
Chinese Academy of Medical Sciences, Fuwai Hospital 1,078
Not applicableStudy completedNCT07134738
What this trial is testing

Dimolegin® (60 mg) for Patients With Moderate COVID-19: A Non-Interventional Study

Who this might be right for
COVID-19
Avexima Diol LLC 184
Next Page